Topics

Pharmaceutical Research and Manufacturers of America

Dec 28, 2017 | Susan Morse
The most important developments hospital finance and operations executives should understand heading into 2018.
Nov 28, 2017 | Susan Morse
Insurers, providers, pharma urge CMS to reconsider allowing states to set essential health benefit benchmarks.
Nov 21, 2017 | Shefali Luthra, Kaiser Health News
Massachusetts wants the power to negotiate discounts for the drugs it purchases and to exclude drugs with…
Aetna-CVS deal could hinge on consumer benefit
Oct 31, 2017 | Susan Morse
After failed merger with Humana, Aetna would need to convince feds that the merger is more than two industry…
Oct 27, 2017 | Susan Morse
Amazon's potential foray into pharmacy business could squeeze providers' bottom lines…
Oct 06, 2017 | April Dembosky, Kaiser Health News
The bill, if signed by the California governor, would require drug companies to give notice to state agencies and health…
drug prices
Oct 02, 2017 | Jay Hancock, Kaiser Health News
The narrative from PhRMA's publicity campaign is only the rosiest, most self-serving version of pricing say critics.
drug prices
Sep 25, 2017 | Jay Hancock, Kaiser Health News
Heated debates over replacing Obamacare and roadblocks erected via industry cash have slowed down lawmakers despite the…
340B discount program
Sep 18, 2017 | Sarah Jane Tribble, Kaiser Health News
A seemingly minor detail about 340B discount program in ACA has left rural pharmacists struggling to keep medicines in stock.
Jul 24, 2017 | Kaiser Health News
Congressional donations from pharma PACs rose 11 percent in this year's first quarter, compared to first…

Pages